{"disease":{"id":"tyrosinemia-type-i","name":"Tyrosinemia type I","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":1,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"orfadin","indication_name":"Tyrosinemia type I","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Orfadin","company_name":"Cycle Pharmaceuticals Ltd.","drug_phase":"marketed","molecular_target":"4-hydroxyphenylpyruvate dioxygenase, 4-hydroxyphenylpyruvate dioxygenase","drug_class":"","quality_score":20,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03655223","title":"Early Check: Expanded Screening in Newborns","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30000,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT05687474","title":"Baby Detect : Genomic Newborn Screening","phase":"","overall_status":"COMPLETED","enrollment_count":6824,"lead_sponsor_name":"Centre Hospitalier Universitaire de Liege","has_results":false},{"nct_id":"NCT05910151","title":"Selective Screening of Children for Hereditary Metabolic Diseases by Tandem Mass Spectrometry in Kazakhstan","phase":"","overall_status":"UNKNOWN","enrollment_count":2250,"lead_sponsor_name":"West Kazakhstan Medical University","has_results":false},{"nct_id":"NCT03446586","title":"Hereditary Hepatorenal Tyrosinemia Natural History in Egypt and the Arab World (Multicenter Clinical Study)","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Yassin Abdelghaffar Charity Center for Liver Disease and Research","has_results":false},{"nct_id":"NCT04196959","title":"Evaluation of TYR Sphere","phase":"NA","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Vitaflo International, Ltd","has_results":false},{"nct_id":"NCT06298292","title":"Acceptability/Tolerance of Protein Substitutes in Tablet Form for the Dietary Management of Rare Aminoacidopathies","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":15,"lead_sponsor_name":"metaX Institut fuer Diatetik GmbH","has_results":false},{"nct_id":"NCT04113772","title":"Bio Equivalency 20 Mgm Orfadin and 20 Mgm of Nitisonine","phase":"NA","overall_status":"UNKNOWN","enrollment_count":4,"lead_sponsor_name":"Sutphin Drugs","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}